Risk Management Plans: GVP Module V Revision 2 and Its Local Impact in...

Risk management plans in the EU have undergone significant changes to address the European Medicines Agency (EMA) Guideline on Good Pharmacovigilance Practices (GVP) Module V Revision 2. In this free...(PRWeb January 16, 2020)Read the full story at https://www.prweb.com/releases/risk_management_plans_gvp_module_v_revision_2_and_its_local_impact_in_the_eu_upcoming_webinar_hosted_by_xtalks/prweb16840423.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news